About
Andrea Flynn, PhD, is a biotechnology executive currently serving as Chief Business Officer at Ambrosia Biosciences. Ambrosia says she previously held senior leadership roles at Jazz Pharmaceuticals, ArcherDX, Array BioPharma, and Novavax, focused on investor relations, communications, and strategy. Based on the official sources used here, this profile refers to the biotech executive Andrea Flynn, PhD, not other public figures with the same name.
Areas of interest
biotechpharmaceuticalscardiometabolic diseaseobesity therapeuticssmall-molecule drug discoveryinvestor relationscorporate communicationslife sciences strategy